Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
Jennifer Le Guévelou(Inserm), Thomas Zilli(University of Geneva), Matthias Gückenberger(University of Zurich), Paul Sargos, Dominique Pasquier(Centre National de la Recherche Scientifique), Robert T. Dess(University of Michigan), Alison Tree(Institute of Cancer Research), S. Supiot(Institut de Cancérologie de l'Ouest), Andrew Loblaw(Health Sciences Centre), Mohamed Shelan(University of Bern), Barbara Alicja Jereczek‐Fossa(University of Milan), Vedang Murthy(Institute of Oncology Research), A. Bruynzeel(Amsterdam University Medical Centers), O. Chapet(Université Claude Bernard Lyon 1), Amar U. Kishan(University of California, Los Angeles), Piet Ost(Ghent University Hospital), Shankar Siva(University of Melbourne), Alejandro Berlín(University Health Network), Stefano Arcangeli(University of Milano-Bicocca), Alan Dal Pra(University of Miami), Pierre Blanchard(Inserm), Costantinos Zamboglou(European University Cyprus), Filippo Alongi(Ospedale Sacro Cuore Don Calabria)
Cited by 8
Related Papers
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646